Lawsuits, Tariffs, Growth Slowdown: What Is Ailing Pharma Stocks?
  • WebDesk BTVI
  • May 14 2019

Amey Chalke, Pharma Analyst , HDFC Securites talks about the pharmaceutical industry under the radar, as US Anti-Trust lawsuit probe hurts Indian pharmaceutical firms. The lawsuit accuses drug makers of conspiring to inflate prices of more than 100 drugs and may become a political issue in US with election next year.